| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |